Who has invested in Checkmate Pharmaceuticals?

Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management are named among the investors backing Checkmate Pharmaceuticals.

Checkmate Pharmaceuticals Funding: $85M Raised, Series C

Checkmate Pharmaceuticals funding overview

Checkmate Pharmaceuticals is based in Cambridge, MA. Checkmate Pharmaceuticals has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2020. The round record for Checkmate Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management and 5 others. 11 distinct backers are named across the disclosed rounds.

Checkmate Pharmaceuticals at a glance

Total raised: $85M
Latest round: Series C
Latest round date: June 2020
Headquarters: Cambridge, MA
Notable investors: Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management, BrightEdge, Sofinnova Investments

Frequently asked about Checkmate Pharmaceuticals funding

How much has Checkmate Pharmaceuticals raised?: Checkmate Pharmaceuticals has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Checkmate Pharmaceuticals?: Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management are named among the investors backing Checkmate Pharmaceuticals.
What was the latest Checkmate Pharmaceuticals funding round?: The most recent disclosed round is a Series C, announced in June 2020.
Where is Checkmate Pharmaceuticals based?: Checkmate Pharmaceuticals is based in Cambridge, MA.
When did Checkmate Pharmaceuticals last raise?: The last disclosed Checkmate Pharmaceuticals round closed in June 2020 at Series C.

Checkmate Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Checkmate Pharmaceuticals Funding: $85M Raised, Series C

Checkmate Pharmaceuticals funding overview

Checkmate Pharmaceuticals at a glance

Frequently asked about Checkmate Pharmaceuticals funding

Companies related to Checkmate Pharmaceuticals (36)

Browse related funding lists (9)